Global Advisory Committee on Vaccine Safety, 7–8 June 2017

Overview

The Global Advisory Committee on Vaccine Safety (GACVS), an independent expert clinical and scientific advisory body, provides WHO with scientifically rigorous advice on vaccine safety issues of potential global importance. GACVS held its 36th meeting in Geneva, Switzerland, on 7–8 June 2017. The Committee examined vaccine specific safety issues: pharmacovigilance planning for the pilot implementation programme for the antimalaria vaccine, RTS,S/AS01 (RTS,S) in 3 countries; updates on the safety profiles of Bacillus Calmette-Guérin (BCG) vaccine and human papilloma virus (HPV) vaccine; and the generic issue of development of standards and a template for the review of the safety profile of vaccines during GACVS meetings